SEC Form 4 · accession 0001610717-26-000320
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig Gracey
Officer — Chief Accounting Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 8:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | M | 405 | $6.57 | A | 15,846 | D | |
| Common Stock | Jun 30, 2026 | S | 405 | $22.00 | D | 15,441 | D | |
| Common Stock | Jul 1, 2026 | M | 637 | $6.57 | A | 16,078 | D | |
| Common Stock | Jul 1, 2026 | S | 637 | $23.00 | D | 15,441 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.57 | Jun 30, 2026 | M | 405 | D | — | Oct 23, 2034 | Common Stock | 405 | 35,012 | D |
| Stock Option (Right to Buy)F2 | $6.57 | Jul 1, 2026 | M | 637 | D | — | Oct 23, 2034 | Common Stock | 637 | 34,375 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F225% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.